Ticker Details
Vivos Therapeutics, Inc.
IPO Date:	July 7, 2020
Sector:	Healthcare
Industry:	Medical Devices
Market Cap:	$8.48M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.18 | 5.04%
Avg Daily Range (30 D):	$0.05 | 4.95%
Avg Daily Range (90 D):	$0.06 | 4.35%

Institutional Daily Volume
Avg Daily Volume:	.87M
Avg Daily Volume (30 D):	.23M
Avg Daily Volume (90 D):	.19M

Trade Size
Avg Trade Size (Sh.):	279
Avg Trade Size (Sh.) (30 D):	251
Avg Trade Size (Sh.) (90 D):	191

Institutional Trades
Total Institutional Trades:	25
Avg Institutional Trade:	$.96M
Avg Institutional Trade (30 D):	$.65M
Avg Institutional Trade (90 D):	$.65M
Avg Institutional Trade Volume:	.03M
Avg Institutional Trades (Per Day):	3

Market Closing Trades
Avg Closing Trade:	$1.05M
Avg Closing Trade (30 D):	$M
Avg Closing Trade (90 D):	$.84M
Avg Closing Volume:	12.46K

News

Jan 21, 2026 @ 6:00 PM Global Sleep Apnea Devices Market is Expected to C... Source: Delveinsight

Jan 20, 2026 @ 10:31 PM Vivos Therapeutics Announces Closing of Exercise o... Source: Na

Dec 15, 2025 @ 10:30 PM Vivos Therapeutics to Participate in Online Firesi... Source: Vivos Therapeutics, Inc.

Aug 20, 2025 @ 8:24 PM Vivos Reports 7% Sales Drop Source: Jesterai

Jun 27, 2024 @ 11:30 AM Vivos Therapeutics Announces Positive Results From... Source: Vivos Therapeutics, Inc

Financials
	TTM	Q1 2026	Q4 2025
Basic EPS	$-2.14	$-.52	$-.58
Diluted EPS	$-2.14	$-.52	$-.58
Revenue	$19.57M	$5.14M	$3.82M
Gross Profit	$12.09M	$3.06M	$2.99M
Net Income / Loss	$-25.12M	$-7.75M	$-6.95M
Operating Income / Loss	$-22.6M	$-6.62M	$-6.38M
Cost of Revenue	$7.47M	$2.08M	$.84M
Net Cash Flow	$-4.23M	$M	$-1.06M
PE Ratio

Splits
Oct 27, 2023	1:25